Steffen Helqvist

Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial

Thomas Engstrøm, Henning Kelbæk, Steffen Helqvist et al. · The Lancet · 2015 · 947 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Complete Revascularisation +9

Randomized Study on Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions

Terje K. Steigen, Rune Wiseth, Andrejs Ērglis et al. · Circulation · 2006 · 720 citations

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

Jacob Lønborg, Niels Vejlstrup, Henning Kelbæk et al. · European Heart Journal · 2011 · 538 citations · Full text

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial

Patrick W. Serruys, Bernard Chevalier, Yohei Sotomi et al. · The Lancet · 2016 · 534 citations · Full text

Percutaneous Coronary Intervention, Absorb Ii, Everolimus-eluting Metallic Stent +10

Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study

David Erlinge, Akiko Maehara, Ori Ben‐Yehuda et al. · The Lancet · 2021 · 423 citations

Medical Ultrasound, Engineering, Vascular Image +12